Clinical Trials Directory

Trials / Unknown

UnknownNCT03371303

Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations

Conditions

Interventions

TypeNameDescription
OTHERcollection of prescription datacollection of prescription data before and after a hospitalization

Timeline

Start date
2017-11-01
Primary completion
2020-02-01
Completion
2021-02-01
First posted
2017-12-13
Last updated
2017-12-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03371303. Inclusion in this directory is not an endorsement.